https://www.fiercebiotech.com/?page=2 Yes keep the shares consolidated by transfer to Daq listing under ADS conversion or voluntary sale by
8/12/2023 I note SEC lodgement by Co indicates that intends to seek FDA approval in the
quarter ending 30/3/2024. Get the feeling we are being shafted so I might just hang in until Merck
calls.
